Clicky

Dassault Systemes SE(DSY) News

Date Title
Jun 19 Battery Simulation Software Market worth $4.19 billion by 2030- Exclusive Report by MarketsandMarkets™
Jun 17 Avio Digitally Transforms the Development of Innovative Space Technologies with Dassault Systèmes’ 3DEXPERIENCE Platform
May 23 Pharma tech CFO says finance is at the center of AI strategy
Apr 18 Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever
Apr 17 Is Dassault Systemes (DASTY) Stock Outpacing Its Computer and Technology Peers This Year?
Oct 7 Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of September 30, 2024
Oct 7 Dassault Systèmes Employee Sets GUINNESS WORLD RECORDS™ Title in Paracycling in New Milestone for Inclusive Mobility
Sep 5 Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of August 31, 2024
Sep 3 Medidata and Aixial Group partner to streamline clinical trial execution
Sep 3 Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock
Jul 26 Eisai adopts Medidata’s AI-driven platform for clinical trials
Jul 26 Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
Jul 25 Dassault Systèmes: Availability of the 2024 Half-year Financial Report
Jul 25 ASICS and Dassault Systèmes Demonstrate On-Demand, Personalized Footwear
Jul 25 Dassault Systèmes: Second Quarter 2024 Results in Line With Preliminary Announcement - Non-IFRS Diluted EPS up 10% in the First Half
Jul 25 Dassault Systèmes: Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
Jun 20 Dassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital Transformation
Jun 19 Medidata introduces new AI-powered platform for clinical trials
Jun 18 Medidata Launches Clinical Data Studio, Leveraging AI to Modernize the Data Experience in Clinical Trials
Apr 9 Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of March 31, 2024